Growth Hormone Treatment
生长激素治疗
Duration
6-12 months per treatment cycle
Recovery
No recovery needed; ongoing daily injections
Savings
~77% vs US
Average savings compared to US prices
Recombinant human growth hormone therapy for children with growth hormone deficiency, Turner syndrome, or idiopathic short stature. China is a global leader in biosimilar growth hormone production, with companies like GeneScience and Anhui Anke offering WHO-prequalified formulations at significantly lower costs. Treatment protocols follow international endocrinology guidelines with regular monitoring.
Diagnostic Evaluation
Comprehensive endocrine workup including growth hormone stimulation tests, bone age X-ray, IGF-1 levels, and MRI of pituitary gland
Duration: 2-3 daysTreatment Planning
Pediatric endocrinologist determines optimal dosage based on weight, deficiency severity, and growth potential
Duration: 1 dayInjection Training & Initiation
Parents and child trained on subcutaneous injection technique using pen devices; first dose administered under supervision
Duration: 1 dayOngoing Monitoring
Quarterly follow-ups measuring height velocity, IGF-1 levels, and metabolic markers with dose adjustments as needed
Duration: Every 3 months- Chinese biosimilar GH costs 70-80% less than branded US products
- Proven efficacy with 8-12 cm/year growth velocity in responders
- Modern pen injection devices minimize pain for children
- Experienced pediatric endocrinologists with high patient volumes
- Injection site reactions including redness and swelling
- Rare joint pain or fluid retention
- Theoretical concern of increased cancer risk with long-term use
- Possible development of antibodies reducing treatment efficacy
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.